<DOC>
	<DOCNO>NCT00546273</DOCNO>
	<brief_summary>The aim study evaluate safety new vaccine Tuberculosis ( RUTI ) administer healthy adult volunteer , compare placebo ; determine safe dosage range . An initial evaluation immune response vaccine compare placebo also undertaken . In present Phase I clinical trial , four increase dos RUTI test , group compose 6 volunteer . ( Total 24 volunteer ) . The escalation new dose test do safety previous dose ensure . For dose FCMtb test , volunteer inoculate twice ( day 0 day 28 ) RUTI ( 4 volunteer ) placebo ( 2 volunteer ) followed-up 25 week first inoculation . The global length study approximately 15 month .</brief_summary>
	<brief_title>Clinical Trial Study 4 Different Doses Vaccine RUTI Healthy Volunteers</brief_title>
	<detailed_description>RUTI therapeutic vaccine make virulent M.tuberculosis bacteria , grown stressful condition , fragment , detoxify , heat inactivate ( FCMtb ) liposomed . RUTI provide strong humoral cellular immune response antigens active grow latent bacillus also structural antigen , prove animal model latent tuberculosis infection . The vaccine design used Latent Tuberculosis Infection therapeutic vaccine 1-month chemotheraputic treatment , instead current treatment base 6-9 month chemotherapy .</detailed_description>
	<mesh_term>Tuberculosis</mesh_term>
	<mesh_term>Latent Tuberculosis</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Signed informed consent Healthy , base medical examination inclusion Male Caucasian subject , age 18 40 year Willing likely able comply trial procedure Evidence previous , current latent tuberculosis , radiological finding chest X ray compatible previous current infection tuberculosis Positive TSPOT TB result BCGvaccinated subject History severe organsystem disease , include History allergic disorder know hypersensitivity drug vaccine , vaccine study component Personal familiar history autoimmune disease , Positive Antinuclear Antibodies HIV , HBV HCV seropositive Suspected known current drug and/or alcohol abuse ( define alcohol intake &gt; 50 g day Lost 400 mL blood within 12 week , 250 mL within 4 week , recruitment Laboratory parameter outside normal range consider clinically significant Intake trial medication clinical trial within 1 month first vaccination Intake drug could eliminate body first vaccination , especially antiinflammatory nonsteroid corticosteroid drug Acute disease &gt; 37ÂºC temperature within 72 hour first vaccination</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>May 2009</verification_date>
	<keyword>LTBI ( Latent tuberculosis infection )</keyword>
	<keyword>TB ( Tuberculosis )</keyword>
	<keyword>Vaccine</keyword>
</DOC>